UA83813U - Method for treating neurosyphilis with mesenchymal alterations - Google Patents
Method for treating neurosyphilis with mesenchymal alterationsInfo
- Publication number
- UA83813U UA83813U UAU201305640U UAU201305640U UA83813U UA 83813 U UA83813 U UA 83813U UA U201305640 U UAU201305640 U UA U201305640U UA U201305640 U UAU201305640 U UA U201305640U UA 83813 U UA83813 U UA 83813U
- Authority
- UA
- Ukraine
- Prior art keywords
- neurosyphilis
- mesenchymal
- treating
- alterations
- nootropic
- Prior art date
Links
- 230000004075 alteration Effects 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 208000002040 neurosyphilis Diseases 0.000 title abstract 2
- FCPVYOBCFFNJFS-LQDWTQKMSA-M benzylpenicillin sodium Chemical compound [Na+].N([C@H]1[C@H]2SC([C@@H](N2C1=O)C([O-])=O)(C)C)C(=O)CC1=CC=CC=C1 FCPVYOBCFFNJFS-LQDWTQKMSA-M 0.000 abstract 1
- VAAUVRVFOQPIGI-SPQHTLEESA-N ceftriaxone Chemical compound S([C@@H]1[C@@H](C(N1C=1C(O)=O)=O)NC(=O)\C(=N/OC)C=2N=C(N)SC=2)CC=1CSC1=NC(=O)C(=O)NN1C VAAUVRVFOQPIGI-SPQHTLEESA-N 0.000 abstract 1
- 229960004755 ceftriaxone Drugs 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 238000001990 intravenous administration Methods 0.000 abstract 1
- 230000001777 nootropic effect Effects 0.000 abstract 1
- 230000002792 vascular Effects 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
A method for treating neurosyphilis with mesenchymal alterations provides for intravenous administration of benzyl penicillin sodium salt and Ceftriaxone for 21 days each in corresponding course modes. The daily doses are calculated according to the body mass. In addition, nootropic and vascular drugs are provided.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UAU201305640U UA83813U (en) | 2013-04-30 | 2013-04-30 | Method for treating neurosyphilis with mesenchymal alterations |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UAU201305640U UA83813U (en) | 2013-04-30 | 2013-04-30 | Method for treating neurosyphilis with mesenchymal alterations |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA83813U true UA83813U (en) | 2013-09-25 |
Family
ID=52279152
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UAU201305640U UA83813U (en) | 2013-04-30 | 2013-04-30 | Method for treating neurosyphilis with mesenchymal alterations |
Country Status (1)
| Country | Link |
|---|---|
| UA (1) | UA83813U (en) |
-
2013
- 2013-04-30 UA UAU201305640U patent/UA83813U/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY189466A (en) | Methods of modulating drug plasma levels using erythrohydroxybupropion | |
| PH12014501997A1 (en) | Esketamine for the treatment of treatment-refractory or treatment-resistant depression | |
| UA117451C2 (en) | Therapeutically active compounds and their methods of use | |
| PH12016500164B1 (en) | Therapeutically active compounds and their methods of use | |
| MX373851B (en) | METHODS OF ADMINISTRATION OF PIRFENIDONE TREATMENT. | |
| SG10201806787VA (en) | Modulators of complement factor b | |
| SG10201903112WA (en) | Treatment of cancer using coenzyme q10 combination therapies | |
| EP4606430A3 (en) | Use of il-22 dimer in manufacture of a medicament for intravenous administration | |
| TW201613592A (en) | Glucose metabolism ameliorating agent | |
| MX370898B (en) | Therapeutic and/or preventive agent comprising 1-indansulfamide derivative for pain. | |
| MX366309B (en) | Pharmaceutical composition for treating inflammation and pain. | |
| MX2014014816A (en) | Pharmaceutical composition for treating inflammation and pain. | |
| MX2017012449A (en) | Pain treatment. | |
| MX2014014817A (en) | Compounds for treating inflammation and pain. | |
| NZ712584A (en) | Antitumor agent including irinotecan hydrochloride hydrate | |
| UA83813U (en) | Method for treating neurosyphilis with mesenchymal alterations | |
| UA82641U (en) | Method for treating neurosyphilis with parenchymatous alterations | |
| GEP20196947B (en) | Bremelanotide therapy for female sexual dysfunction | |
| MX2016002139A (en) | Pharmaceutical composition and use of diethyl (2-cyanoethyl)phosphonate. | |
| RU2012123184A (en) | METHOD FOR CONTROLLED REDUCTION OF THE AGGREGATION ACTIVITY OF THROMBOCYTES BY MEXIDOL IN THE EXPERIMENT | |
| UA79767U (en) | Method for treating cerebral ischemic stroke with abnormalities of intracerebral and precerebral arteries in acute period | |
| UA86768U (en) | Method for treating generalized periodontitis grade ii-iii | |
| RU2012115039A (en) | METHOD FOR TREATING CHRONIC ENDOMETRITIS | |
| MX2016010919A (en) | 4-benzylsulfonyl-2-butenenitrile. | |
| UA95834U (en) | Method for treating acute ischemic stroke |